Prostate cancer (PCa) is the most frequently diagnosed cancer in Canadian men and the third deadliest. If the majority of PCa are well treated using first line treatments like surgery, radiation and/or androgen deprivation therapy (ADT), a proportion of cases (10%) progress to metastatic cancer resulting in more than 4 000 deaths annually in Canada. Improving the efficacy of first line treatments is a challenge to prevent the apparition of more aggressive PCa metastatic stage. Cancer therapies do not necessarily trigger simple cancer cell death.
In this project, we will establish biomarkers that objectively reflect the severity of injury, measure its progression, and predict neurologic outcome after acute spinal cord injury (SCI). This will be accomplished by comprehensively analyzing blood and spinal fluid samples from acute SCI patients. In addition, we will conduct a parallel experimental study in a large animal model of SCI with a similar analysis of blood and spinal fluid samples.
Hypoxic cells comprise most aggressive and therapy resistant population in the tumors therefore targeting proteins that are essential for hypoxia survival is an effective novel anti-cancer treatment. We have an ability to generate highly specific humanized synthetic antibodies against target of choice. We will generate antibodies against proteins that promote hypoxia survival, test their effect in 2D/3D systems and will move to preclinical/clinical trials upon successful in vitro validation.
Reduced number of insulin producing ?-cells in pancreas due to increased ?-cell death is a key defect in diabetes that eventually leads to elevated blood glucose levels and life-time treatment with glucose lowering drugs or daily insulin injections. Thus, finding therapeutic approaches to prevent the decrease in the number of insulin producing ?-cells in diabetic patients either by reducing ?-cell death or by increasing their proliferation is of great importance.
PUBLIC is an innovative art journal published by Public Access exploring the intersection between art, technology and contemporary culture. This fellowship develops PUBLICs open access interactive web platform, PUBLIC:PORTAL, using information visualization and design to showcase the journals cutting-edge collaborative and cross-disciplinary work. Working with the Sensorium Centre for Digital Arts and Technology at York University, PUBLICs information designers, as well as Public Accesss network of artists and researchers, the fellow will develop the pilot issue of PUBLIC:PORTAL.
To perform a complete molecular analysis of muscle invasive bladder cancer (MIBC) before and after pre-operative chemotherapy to find changes responsible for resistance to treatment. Analysis will include a combination of DNA sequencing, RNA expression analysis and quantification of protein. Together this information will reveal the molecular landscape for these tumors.
Perfusion imaging with a CT scanner provides important information about blood flow and, in acute ischemic stroke, highlights regions of brain infarct, where tissue has died because of a lack of blood flow. This infarct region continues to grow over time until blood flow is restored. Being able to predict the rate of infarct growth would provide doctors with a key piece of information (currently unavailable) that would help them decide on a course of treatment.
As the Canadian population is aging, more and more Canadians will show cognitive decline. Aging and certain types of
neurological disorders is often associated with deficits in executive functions: goal maintenance, planning, task
switching and attention. These functions are critical for the maintenance of functional independence. Few validated
rehabilitation approaches for these types of deficits exist. One rehabilitation approach, Goal Management Training
(GMT), has shown promise. In its standard implementation, GMT is led in small groups.
Rapid identification of bacteria in blood is important for the early identification of infection and emergence of resistance to therapy. There is no wishful, fast and simple, technological solution for this quest. Some of infections are life-threatening and requires fast and focused drug treatment as soon as possible. The present approach is to use empirical therapy and wait for culture results (if positive) to modify treatment, i.e. to remove unaffected drugs and add/increase drugs which will attenuate identified pathogen.
Hearing aids are now fully digital, advanced signal processors. Studies show that the sound quality of todays hearing aids is important, and may impact how a hearing aid user enjoys music. Few tools are available for clinicians to measure hearing aid sound quality in daily practice. In this project, we will develop and implement a tool for this purpose.